Presentation is loading. Please wait.

Presentation is loading. Please wait.

Medicines Transparency Alliance18/12/2015 1 Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.

Similar presentations


Presentation on theme: "Medicines Transparency Alliance18/12/2015 1 Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator."— Presentation transcript:

1 Medicines Transparency Alliance18/12/2015 1 Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator

2 Medicines Transparency Alliance18/12/20152 Multi-stakeholder process Situation analysis of multi-stakeholders in the Country Organization of MeTA Council in Kyrgyzstan Regular meetings engaging multi-stakeholders Formation of MeTA CSOs Coalition Private sector from remote regions of KG more interested in MeTA than central regions CSOs was active in dialogues with private and government sectors Procurement and availability of medicines is the main issues for CS and private sectors: – Implementation of CS observers in tenders (Gov bodies are inviting) – Private sector suggested to implement E-procurement system in hospitals

3 Medicines Transparency Alliance Major achievements and successes Common forum for discussion on pharmaceutical issues Availed platform for Problem solving on significant issues in the sector, including WEB-site (has launched, content in the process of filling) Conduct inter sectoral collaboration via design of activities allowing data gathering and information Improved communication and awareness of different sectors MoH KG Private sector initiated to organise small active group on Legislation issues and regular meetings. Capacity building of the CSO Coalition is considered as the major success in Kyrgyzstan 18/12/20153

4 Medicines Transparency Alliance Overall challenges Current political situation with constrained government management (poor transparency and accountability) Private sector involvement limited due to inadequate information on how to engage in MeTA process How to show the benefit of MeTA to every sector Poor leadership of MeTA Council due to conflict of interest (Director of DRA is chairman of MeTA Council) Overcoming conflict of Interest and engagement between sectors (better understanding of each other & role of each sector in the country) Active promotion of MeTA was not possible because of political situation 18/12/20154

5 Medicines Transparency Alliance Lessons Learned Different background of MeTA Council Member complicate the dialogue Development of Criteria for management of MeTA Council requires wider consideration than sectoral interest Engagement of Multi stakeholder is a Process and takes time Requires skills to engage and manage the different sectors (particularly to listen to the other sector and increase awareness) MSP requires good facilitation and these skills need to be development and learnt Power in numbers… (when we are many we are stronger) Benefit is important: Private sector wants to be involved more active in Legislation issues. Media strategy for promoting MeTA it must be at the beginning of process 18/12/20155

6 Medicines Transparency Alliance18/12/20156 Thank you Mariam Djankorozova MeTA Country coordinator Email: mariamkad@gmail.com Mobile number: +996 555 92 94 12 Skype: mariamdjan1 Website: www.metakg.org


Download ppt "Medicines Transparency Alliance18/12/2015 1 Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator."

Similar presentations


Ads by Google